Before testing the combination effect of TRAIL and the Bcl-2 family inhibitors, we examined the expression of anti-apoptotic Bcl-2 family proteins (Bcl-2, Bcl-xL, and Mcl-1) in nine cancer cell lines (Figure 2A). The gene discussed is MCL1; the disease is cancer.